All Themes

CMS is moving cost-and-affordability policy toward more direct provider accountability: the proposed resurrection and nationwide expansion of mandatory joint replacement bundles through CJR-X would deepen episode-based risk for hospitals and MSK networks, while TEAM reinforces that mandatory bundles are becoming a core Medicare cost-control tool rather than a niche demonstration ([Hall Render on CJR-X](https://hallrender.com/2026/04/17/cms-proposes-resurrection-and-nationwide-expansion-of-mandatory-joint-replacement-bundled-payment-model-cjr-x/)). At the same time, CMS is testing the voluntary ACCESS model with 150 participants, linking chronic disease payment to outcomes enabled by technology partners—signaling a parallel strategy of using scalable tech-enabled care management to lower longitudinal total cost of care ([Healthcare Finance on ACCESS](https://www.healthcarefinancenews.com/news/lean-payment-voluntary-participation-test-new-access-model)). For health systems, ACOs, and payers, the strategic tension is clear: Medicare VBC is expanding both mandatory downside exposure in procedural episodes and optional infrastructure-heavy models in chronic care, raising the premium on data integration, specialist alignment, post-acute control, biosimilar adoption, and repeatable cost-management playbooks.

CMS’s new ACCESS and LEAD models are becoming near-term catalysts for VBC infrastructure investment, with vendors and provider partners positioning around data aggregation, workflow automation, risk stratification, and model participation support rather than just point-solution care management. At the same time, the Medicare Advantage 2027 final rule is reshaping Star Ratings economics and quality-measure strategy, increasing pressure on MA plans, ACO-aligned providers, and enablement firms to tighten documentation, quality performance, and audit readiness under the Trump administration’s CMS leadership. The market signal is a shift from “VBC participation” to backend operating capability—seen in ACCESS partnerships, behavioral health VBC infrastructure efforts, and AI-enabled risk adjustment tools—while stakeholders navigate the tension between innovation opportunities and heightened scrutiny around MA coding, quality measurement, and ROI ([CMS ACCESS/LEAD opportunity](https://news.google.com/rss/articles/CBMi4AFBVV95cUxQNzhUQkdUR3NkM1lPaXoxN19jbTlHVkQ5amNweVR5SGZiakFOTjhLaXdoUFFjLTh1aDd3RXRzc015TDFfXzYwVnphdi1FVFFaR0JYYmtqN2ZLUVNxRU1ieC1makhvbVBmWEZZQ1pweklDWmlKUVpaVE11NElxVjlEQVRLY1)

CMS is pushing VBC through a more diversified model portfolio: the LEAD ACO model aims to broaden accountable care participation beyond traditional MSSP entrants, while ACCESS tests leaner, tech-enabled chronic disease management contracts with 150 participants and voluntary provider participation—signaling a Trump-era CMMI emphasis on scalable prevention, competition, and taxpayer protection. At the same time, CMS’s proposed resurrection and nationwide expansion of mandatory joint replacement bundles (CJR-X) reintroduces compulsory specialty risk, creating a strategic split for providers between voluntary primary-care/population-health models and mandatory episode-based accountability. For health systems, ACOs, and payers, the near-term positioning question is no longer whether VBC expands, but where to build capabilities first: MSSP/LEAD attribution and longitudinal care management, ACCESS-style technology partnerships, or orthopedic bundle performance infrastructure. [LEAD model overview](https://news.google.com/rss/articles/CBMizwFBVV95cUxPUEhSYU0tVElBdDRJd0FVNFpDaHlxODBaalZ1dmJWdHV3U3JBSkg1QmI3MmphVVFsdUpJRmJqbXBndnF2NV9GbXQ1RzVxckU0TEl4eVdabUd1ZVdDU1JqN0wyQTc5SjBfU3d0dmpWNHI5V

CMMI is positioning interoperability and analytics infrastructure as core VBC operating requirements through tech-enabled models such as ACCESS and LEAD, with ACCESS emphasizing chronic-care management, digital engagement, prevention, and scalable risk-bearing capabilities under the Trump administration’s “Make America Healthy Again” CMMI direction. The market response—vendors such as Innovaccer framing ACCESS/LEAD as infrastructure opportunities and digital-health participants like ALYKA entering ACCESS—signals that payer-provider alignment is increasingly being mediated by data platforms capable of attribution, quality measurement, care-gap closure, and performance management rather than by contract design alone. For ACOs, safety-net providers, and specialty groups, the strategic tension is whether health IT investments can translate into measurable quality and cost performance across models like ACCESS, TEAM, and CJR-X while avoiding another layer of operational complexity and vendor dependency ([ACCESS model explainer](https://www.healthcare-economist.com/2026/04/27/cmmis-advancing-chronic-care-with-effective-scalable-solutions-access-model-explained/); [tech-enabled ACCESS coverage](https://news.google.com/rss/articles/CBMiygFBVV95cUxQOGRNRTN3RnJ1c1NPYUdCZ2VjSDB2dEgtTzRfaEpzRjVYR3BEeVo3cnA1bHRHNldIQzBVekZiR0VGNHlOYlly)

CMS is pushing care coordination and chronic disease management toward tech-enabled, outcomes-tied payment through CMMI’s voluntary ACCESS model, which launches July 5 with 150 participants and links provider payment to chronic disease management performance with technology partners—signaling a Trump administration CMMI strategy that favors scalable enablement, leaner payment design, and voluntary uptake before broader risk expansion ([Healthcare Finance](https://www.healthcarefinancenews.com/news/lean-payment-voluntary-participation-test-new-access-model)). At the same time, CMS is moving to expand bundled accountability in joint replacement care, reinforcing that specialty episodes and longitudinal chronic care are both becoming core fronts for Medicare value-based care strategy ([AAPC](https://www.aapc.com/blog/94077-cms-seeks-to-expand-joint-replacement-care-model/)). For ACOs, health systems, and payers, the strategic tension is shifting from whether to invest in care management infrastructure to how quickly they can integrate analytics, workflow technology, physician alignment, and risk-contract operations across both population-based and episode-based models.

CMS’s ACCESS model is moving from concept to operations, with 150 voluntary participants launching July 5 and payments tied to chronic disease outcomes enabled by technology partners—signaling the Trump administration’s continued push toward lighter, tech-enabled VBC models that reduce provider burden while testing whether digital care management can reliably drive measurable savings and quality gains ([ACCESS model participants](https://www.healthcarefinancenews.com/news/lean-payment-voluntary-participation-test-new-access-model)). At the same time, ACO strategy is shifting from participation growth to execution risk: MSSP reform proposals, LEAD model readiness concerns, MIPS overhaul efforts, and provider investments in HCC coding and AI “care execution” tools all point to a market preparing for tighter benchmarking, more precise risk adjustment, and greater operational accountability across Medicare value-based contracts ([MSSP participation and savings](https://news.google.com/rss/articles/CBMivwFBVV95cUxNLV9UR21OdFNDU1QxOGNaRFhPNkJHMHpnbHBLb2J2b05Tekx4N1luUm5GSGxpVDJSM2JQUS1Ic1hBQmxnSlg5WkhDc2wwbUFVcE1HZVpiMjM5UXY5ekdwVU1RZ2hJYjQyeVhTa0Y4YkZrZmlFR1RqWTM0)

Payment integrity is becoming a defining constraint on VBC strategy as CMS, DOJ, and plans intensify scrutiny of Medicare Advantage risk adjustment, audit readiness, Stars disputes, and AI-enabled utilization controls; recent settlements and fraud litigation around MA coding practices are reinforcing that documentation infrastructure must support both revenue accuracy and defensible compliance. At the same time, AI is being positioned as both a solution and a risk vector: vendors are marketing more “ethical” risk adjustment and audit platforms, while reports of Medicare AI prior authorization delays in Washington raise access and provider-burden concerns that could shape how CMS governs automation in payment models and care management ([AI prior authorization delays](https://www.healthcaredive.com/news/medicare-ai-prior-authorization-pilot-care-delays-washington-senator-maria-cantwell/818348/)). Medicaid drug-cost innovation is also moving into the payment-integrity frame, with the GENEROUS model’s savings potential dependent on confidential operational details and state/federal implementation choices—important for ACOs and risk-bearing organizations exposed to pharmacy trend, affordability metrics, and total-cost benchmarks ([KFF on GENEROUS](https://www.kff.org/medicaid/a-look-at-the-generous-model-and-factors-that-could-impact-medicaid-drug-costs/)).

CMS under the Trump administration is using CMMI to push tech-enabled chronic care management into value-based payment, with the voluntary ACCESS model launching July 5 and naming 150 participants that pair providers with technology companies and tie payment to chronic disease outcomes—an approach especially relevant to safety-net and Medicaid-adjacent populations with high chronic disease burden. The model’s lean payment design and voluntary structure create a strategic test for ACOs, FQHC-aligned organizations, and digital health vendors: whether scalable infrastructure can improve outcomes without large upfront federal subsidies, while positioning vendors such as Innovaccer, Story Health, ALYKA Health, and Aledade around CMS’s emerging VBC operating model. In parallel, the proposed LEAD model signals a broader effort to expand accountable care access for underserved beneficiaries, making safety-net participation, data infrastructure, and chronic care execution central competitive capabilities for VBC stakeholders ([ACCESS model overview](https://www.healthcarefinancenews.com/news/lean-payment-voluntary-participation-test-new-access-model); [LEAD model analysis](https://news.google.com/rss/articles/CBMizwFBVV95cUxPUEhSYU0tVElBdDRJd0FVNFpDaHlxODBaalZ1dmJWdHV3U3JBSkg1QmI3MmphVVFsdUpJRmJqbXBndnF2NV9GbXQ1RzVxck

CMS is pushing Medicare value-based care in two directions at once: broadening accountable care participation through the Long-Term Enhanced ACO Design (LEAD) Model while also reviving more compulsory episode-based payment with a proposed nationwide expansion of the Comprehensive Care for Joint Replacement model (CJR-X). The ACCESS model adds a third signal—CMMI is testing lower-payment, voluntary, tech-enabled chronic care arrangements that tie Medicare payments to outcomes—suggesting Dr. Mehmet Oz’s CMS and Abe Sutton’s CMMI are prioritizing scalable models that combine taxpayer protection, provider accountability, and private-sector enablement. For ACOs, hospitals, and VBC enablement firms, the strategic tension is shifting from “whether” Medicare will expand risk-based payment to “which risk architecture wins”: longitudinal ACO/population-health models like [LEAD](https://news.google.com/rss/articles/CBMizwFBVV95cUxPUEhSYU0tVElBdDRJd0FVNFpDaHlxODBaalZ1dmJWdHV3U3JBSkg1QmI3MmphVVFsdUpJRmJqbXBndnF2NV9GbXQ1RzVxckU0TEl4eVdabUd1ZVdDU1JqN0wyQTc5SjBfU3d0dmpWNHI5V3Zndlc3VDc3UT

CMS is pushing health equity and SDoH into the operational core of VBC rather than treating them as standalone initiatives: the ACCESS Model is being positioned as validation of safety-net innovation in Traditional Medicare, while commentary around risk-based infrastructure emphasizes that organizations need better data, attribution, and care-management technology to perform under downside risk. At the same time, CMS’ proposed elimination of the Excellent Health Outcomes for All reward program signals a pullback from explicit equity-linked payment bonuses, creating a strategic tension for ACOs, safety-net providers, and MA plans between continuing equity-focused population health investments and adapting to a payment environment that may reward them less directly ([ACCESS and safety-net innovation](https://news.google.com/rss/articles/CBMiugFBVV95cUxOV2RBVk1tT2dNNlNCNXdUT3VkWmwwSlJlazdCX0xIajZrWnlQYzM2dnkwX25kN2xzYkNZZHdXSmV2cy1nZDNnZS1EQlJQeXZxY3dLT2c5RVVCSHF3QkpOdWhRUm9qUGVFT29QRUJCV0JKempTdVZ0eFR1bHRZU1U3UlJnM2FzY3lNNWNOT0E1NU1fT2pmSkhWRVpxdEtKbEdENH

CMS is pushing population health management toward more tech-enabled, outcomes-tied chronic care infrastructure through CMMI’s voluntary ACCESS model, which launches July 5 with 150 participants and links payment to chronic disease management results achieved with technology partners—an important signal from the Trump administration’s CMS that scalable care execution, not just attribution, will be central to future VBC strategy ([ACCESS model overview](https://www.healthcarefinancenews.com/news/lean-payment-voluntary-participation-test-new-access-model)). At the same time, ACOs, safety-net providers, and health systems are positioning around AI-enabled care management, total-cost-of-care specialty models, and quality-measurement alignment, but the core tension remains whether “lean” voluntary models can generate enough operational investment and downside-risk readiness to materially improve outcomes and costs across populations ([ACCESS and safety-net innovation](https://news.google.com/rss/articles/CBMiugFBVV95cUxOV2RBVk1tT2dNNlNCNXdUT3VkWmwwSlJlazdCX0xIajZrWnlQYzM2dnkwX25kN2xzYkNZZHdXSmV2cy1nZDNnZS1EQlJQeXZxY3dLT2c5RVVCSHF3QkpOdWhRUm9qUGVFT29QRUJCV0JKempTdVZ0eFR)

CMS under the Trump administration is pushing quality accountability back toward mandatory and technology-enabled models: the proposed nationwide CJR-X episode-payment model would revive compulsory joint-replacement bundles with quality and cost performance at stake, while ACCESS will test chronic-disease payment tied to outcomes generated through tech-enabled care partners. At the same time, ACO and provider strategy is shifting from reporting-oriented quality management to operational control—care management infrastructure, biosimilar adoption, payer-provider data alignment, and AI-enabled measurement are becoming core levers for Stars, shared savings, and downside-risk performance. The near-term tension for VBC stakeholders is whether CMS can simplify measurement and reduce administrative burden while expanding models that demand tighter attribution, real-time intervention, and provable quality improvement across Medicare populations ([CJR-X proposal analysis](https://hallrender.com/2026/04/17/cms-proposes-resurrection-and-nationwide-expansion-of-mandatory-joint-replacement-bundled-payment-model-cjr-x/); [ACCESS model launch](https://www.healthcarefinancenews.com/news/lean-payment-voluntary-participation-test-new-access-model)).

CMS’s ACCESS Model is emerging as the key primary-care-adjacent Medicare innovation signal under the Trump administration, with attention shifting from broad digital-health participation to more targeted chronic-condition, specialty-interface, and AI-enabled care redesign—raising questions about why major digital health firms are sitting out and how primary care groups, cardiology practices, and ACOs should position around attribution, workflow, and downside-risk readiness ([STAT on ACCESS participation](https://www.statnews.com/2026/05/14/medicare-chronic-care-pilot-access-digital-health-tech/?utm_campaign=rss); [Aledade on AI and ACCESS](https://news.google.com/rss/articles/CBMimwFBVV95cUxOcGlzSVhmU19lVnFVeUlsQnpWYUxWMWxhYjRuUHZoNDdVNmxoSFlheWJLbk9JMXVQZmM1VXc0WU0tMDZwcUdnaTVqVm9BVlRnbU5SUVdzRW93Mm5WVlYxaThNME5SNXJwNjA0OVBjVXNHZV91R3N0aFBkNkJXZll5UVFYbk15ZGlnWTFvXzhhODFPVWhZZkNReE1DMNIBqwFBVV95cUxPc01XTUpzcWhpXzBwVWJ0N25

CMS is tightening the infrastructure around home- and community-based care and post-acute accountability, with proposed 2028 HCBS quality measures signaling a longer-term push to standardize Medicaid HCBS performance measurement while home health stakeholders parse implications for staffing, reporting burden, and VBC readiness ([HCBS quality measures](https://homehealthcarenews.com/2026/04/cms-unveils-proposed-2028-hcbs-quality-measure-set-what-it-means-for-home-care-providers/)). At the same time, Medicare Advantage remains a pressure point for care delivery transformation: bipartisan MA reform efforts and CMS Administrator Dr. Mehmet Oz’s prior authorization agenda indicate growing federal scrutiny of utilization management that can constrain home health, hospice, and post-acute access even as plans pursue lower-cost care settings. The strategic throughline for ACOs, LTC operators, hospice, and home-based providers is clear: VBC opportunities are expanding beyond physician-led MSSP-style models, but participation gaps in programs like LEAD and operational friction in MA show that success will depend on data capability, quality performance, and contracting leverage rather than nominal alignment with value-based care.

CMS/CMMI under the Trump administration is widening the VBC portfolio in two directions at once: expanding accountable care access through the Long-Term Enhanced ACO Design (LEAD) model while testing tech-enabled chronic care management through the voluntary ACCESS model, which launches July 5 with 150 participants and ties payment to outcomes rather than service volume ([LEAD model overview](https://news.google.com/rss/articles/CBMizwFBVV95cUxPUEhSYU0tVElBdDRJd0FVNFpDaHlxODBaalZ1dmJWdHV3U3JBSkg1QmI3MmphVVFsdUpJRmJqbXBndnF2NV9GbXQ1RzVxckU0TEl4eVdabUd1ZVdDU1JqN0wyQTc5SjBfU3d0dmpWNHI5V3Zndlc3VDc3UTVsbkx4X3NYdUJaTkN4b2NJckw3N2NTSnkyS0NWRlUxdlBtN3FINE04alcybVZFZFRWcWdoNEZSMGkxQ3I0NjJySGdiZHRSX09HUWJZcE9YMU1ZaTg?oc=5), [ACCESS model details](https://www.healthcarefinancen

Risk adjustment is becoming a central operating-risk issue for VBC organizations as CMS model participation and MA economics increasingly depend on defensible coding, data completeness, and audit-ready documentation rather than retrospective revenue capture. ACOs evaluating CMS’s new LEAD model face material uncertainty around beneficiary risk profiles and data gaps, while health systems and vendors are moving toward embedded HCC workflow tools and AI-enabled documentation integrity platforms to support accurate stratification and compliant reimbursement ([Wakely on LEAD participant risks](https://www.wakely.com/blog/risks-facing-2027-LEAD-model-participants/); [Premier/AtlantiCare HCC coding initiative](https://premierinc.com/newsroom/blog/atlanticare-enhances-hcc-coding-with-premiers-stanson-health-codingguide-driving-quality-and-efficiency)). At the same time, Medicare Advantage risk adjustment remains under enforcement and reputational pressure, with DOJ activity, false-claims settlements, and scrutiny of aggressive assessment tactics reinforcing a strategic tension: plans and risk-bearing providers need better capture of true disease burden, but must shift from coding maximization to clinically substantiated, audit-resilient risk adjustment.

Medicare Advantage is entering a more constrained operating cycle: CMS’s 2027 MA rule and payment updates are reshaping consumer protections, Star Ratings, and plan economics, while enrollment growth has slowed sharply and provider groups are pressing Congress for prior authorization and network reforms through the House Medicare Advantage Improvement Act. For VBC stakeholders, the strategic tension is shifting from MA growth-at-all-costs toward tighter risk selection, network adequacy, utilization management oversight, and payer-provider contracting discipline, especially as hospitals and home health providers push back on plan behavior and benefit design changes ([KFF on 2027 MA policy changes](https://www.kff.org/medicare/changes-to-the-medicare-advantage-program-enhance-some-consumer-protections-but-roll-back-others/); [HFMA on MA turmoil](https://www.hfma.org/fast-finance/medicare-advantage-turmoil-continues/)). At the same time, evidence that the Oncology Care Model reduced chemotherapy use and Medicare spending in poor-prognosis cancers reinforces CMS/CMMI’s broader opportunity under Abe Sutton to prioritize specialty payment models that align utilization reduction with quality, not just total-cost accountability.

CMS is signaling a more assertive Trump administration push toward mandatory and specialty-focused value-based payment, with the proposed nationwide resurrection of the Comprehensive Care for Joint Replacement model as “CJR-X” and continued attention to TEAM positioning hospitals and orthopedic networks for downside-risk episode management at scale. At the same time, newer models such as ACCESS and LEAD suggest CMMI is pairing mandatory bundles with targeted population- and safety-net-oriented VBC pathways, creating a strategic tension for health systems and ACOs: build enterprise episode-of-care infrastructure now or risk being forced into fragmented model-by-model compliance. For VBC leaders, the near-term priority is aligning MSK, behavioral health, post-acute, and safety-net partnerships around attribution, data exchange, and risk-bearing capabilities as CMS expands the policy toolkit beyond voluntary participation ([CJR-X proposal analysis](https://hallrender.com/2026/04/17/cms-proposes-resurrection-and-nationwide-expansion-of-mandatory-joint-replacement-bundled-payment-model-cjr-x/); [ACCESS model participants](https://news.google.com/rss/articles/CBMivAFBVV95cUxPMnFvS19rbERmNmUzQ3BMdUdQMFc5MUtycWJxQ2ZxdUZyZEUzUVVrOGtUdFhLWUJpTmlaOVZFbnB0REpCR3JSVVk5VkVGb=))